Skip to content

Baduanjin review suggests better walking capacity after heart attack treatment

Randomized trials reported gains in walking capacity and other rehabilitation measures, but the abstract leaves comparison care and follow-up details unclear.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

The review suggests that Baduanjin, a traditional Chinese exercise, may help rehabilitation after a heart attack treated with PCI. Participants assigned to Baduanjin had better walking-test results, alongside improvements in heart function and quality-of-life measures. However, the abstract does not describe comparison care or treatment duration, limiting how specifically the findings can be interpreted.

Keep in mind

The abstract does not report trial quality assessments, exercise schedules or follow-up lengths. Its favorable safety summary cannot establish that uncommon or longer-term harms have been excluded.

THE NUMBERS, WITH CONTEXT

What researchers found

60.21 m

Difference in 6-minute walk distance

Mean difference favoring Baduanjin; 95% CI 17.96 to 102.46. Trial comparators and assessment timing are not specified in the abstract.

Complement Ther Med, 2026 · Original source ↓

What the main result measures

The walking test measured exercise capacity during rehabilitation. Its improvement describes a functional outcome in this patient group; it does not by itself show fewer future heart attacks or longer survival.

Safety remains a qualified finding

The authors reported no apparent increase in adverse events and a possible reduction in certain cardiovascular events. They nevertheless called for further well-designed studies, so the safety conclusion remains provisional.

CHECK THE ORIGINAL

The original publication

Is Baduanjin beneficial and safe for the rehabilitation of patients with acute myocardial infarction undergoing percutaneous coronary intervention? A systematic review and meta-analysis of randomised controlled trials.

Liang SB, Li YF, Zhang YY et al.
Complement Ther Med · 2026

PubMed ID
41839353
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.